A phase I, dose escalation study to determine the maximum tolerated dose of erlotinib when combined with pertuzumab in previously treated non-small-cell lung cancer patients
Felip, E., Ranson, M., Cedres, S., Dean, E., De Droogh, E., Brewster, M., . . . Galdermans, D. (2008). A phase I, dose escalation study to determine the maximum tolerated dose of erlotinib when combined with pertuzumab in previously treated non-small-cell lung cancer patients. Journal of Clinical Oncology, 26(15_suppl), 19134. doi:10.1200/jco.2008.26.15_suppl.19134
Felip, E., Ranson, M., Cedres, S., Dean, E., De Droogh, E., Brewster, M., . . . Galdermans, D. (2008). A phase I, dose escalation study to determine the maximum tolerated dose of erlotinib when combined with pertuzumab in previously treated non-small-cell lung cancer patients. Journal of Clinical Oncology, 26(15_suppl), 19134. doi:10.1200/jco.2008.26.15_suppl.19134